We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+12.22%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$360M
AUM Growth
+$92.4M
Cap. Flow
+$88.5M
Cap. Flow %
24.56%
Top 10 Hldgs %
19.65%
Holding
155
New
60
Increased
18
Reduced
21
Closed
31

Top Buys

Rank Stock Value
1
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$9.64M
2
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$6.47M
3
ALDX icon
Aldeyra Therapeutics
ALDX
+$6.31M
4
CDNA icon
CareDx
CDNA
+$6.31M
5
VRCA icon
Verrica Pharmaceuticals
VRCA
+$6.28M

Top Sells

Rank Stock Value
1
IRD
Opus Genetics
IRD
+$15.5M
2
GNPX icon
Genprex
GNPX
+$6.81M
3
ANAB icon
AnaptysBio
ANAB
+$5.62M
4
COGT icon
Cogent Biosciences
COGT
+$4.86M
5
CLDX icon
Celldex Therapeutics
CLDX
+$4.47M

Sector Composition

Rank Sector Weight
1 Healthcare 82.98%
2 Financials 2.24%
3 Consumer Staples 0.95%
4 Industrials 0.89%
5 Technology 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATBW
101
DELISTED
FAT Brands Inc. Warrant
FATBW
$1.06M 0.29%
300,000
– –
ROCCU
102
DELISTED
Roth CH Acquisition II Co. Unit
ROCCU
$1.05M 0.29%
100,000
– –
ARYD
103
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$1.05M 0.29%
+100,000
New +$1.08M
CZOO
104
DELISTED
Cazoo Group Ltd
CZOO
$1.03M 0.28%
+50
New +$1.16M
QELL
105
DELISTED
Qell Acquisition Corp. Class A Ordinary Shares
QELL
$1.02M 0.28%
+100,000
New +$1.21M
OPAD icon
106
Offerpad Solutions
OPAD
$23.1M
$1.01M 0.28%
+667
New +$1.09M
FRGE
107
DELISTED
Forge Global Holdings
FRGE
$1M 0.28%
+6,807
New +$1.05M
QNGY
108
DELISTED
Quanergy Systems, Inc.
QNGY
$1M 0.28%
+5,000
New +$1.07M
FMAC
109
DELISTED
FirstMark Horizon Acquisition Corp.
FMAC
$1M 0.28%
+100,000
New +$1.09M
OMEG
110
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$990K 0.27%
+100,000
New +$1.04M
SYRS
111
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$948K 0.26%
+12,670
New +$1.32M
CLDX icon
112
Celldex Therapeutics
CLDX
$3.28B
$927K 0.26%
45,013
-194,507
-81% -$4.47M
VINCW
113
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
$870K 0.24%
215,250
– –
CHAQ.WS
114
DELISTED
Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
CHAQ.WS
$688K 0.19%
731,561
+231,561
+46% +$256K
BCTXW
115
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$535K 0.15%
+500,000
New +$489K
GYRE icon
116
Gyre Therapeutics
GYRE
$744M
$453K 0.13%
11,991
-29,842
-71% -$1.36M
TONX
117
TON Strategy Co
TONX
$169M
$394K 0.11%
+35
New +$535K
WGSWW
118
DELISTED
GeneDx Holdings Warrant
WGSWW
$345K 0.1%
+66,666
New +$371K
IMTXW
119
DELISTED
Immatics N.V. Warrants
IMTXW
$288K 0.08%
97,467
– –
GNPX icon
120
Genprex
GNPX
$2.16M
$263K 0.07%
1
-31
-97% -$6.81M
EVAX
121
Evaxion A/S
EVAX
$25.9M
$146K 0.04%
+495
New +$189K
JSPRW icon
122
Japer Therapeutics Warrants
JSPRW
$133K 0.04%
162,500
– –
OBIO icon
123
Orchestra BioMed
OBIO
$254M
$112K 0.03%
10,000
– –
GLEO.WS
124
DELISTED
Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share
GLEO.WS
$110K 0.03%
200,000
– –
ANAB icon
125
AnaptysBio
ANAB
$1.68B
– –
-261,209
Closed -$5.62M
3 4
5
6 7

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Altium Capital Management held 155 positions worth $360M, up 34% from $268M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Altium Capital Management deployed $88.5M of net new capital in Q1 2021, opening 60 new positions and adding to 18 existing holdings. Its largest new stake was Biora Therapeutics, Inc. Common Stock: 6,993 shares worth $8.32M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 85% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Opus Genetics, an estimated $15.5M trimmed.

  • Altium Capital Management's largest Q1 2021 buy was Biora Therapeutics, Inc. Common Stock: 6,993 shares worth $8.32M.
  • Altium Capital Management added most to Verrica Pharmaceuticals in Q1 2021, an estimated $6.28M increase.
  • Altium Capital Management's biggest Q1 2021 reduction was Opus Genetics, cutting an estimated $15.5M.
  • Altium Capital Management fully exited AnaptysBio in Q1 2021, selling an estimated $5.62M.
  • Altium Capital Management's ten largest holdings make up 20% of its $360M portfolio in Q1 2021.
  • Altium Capital Management opened 60 new positions and closed 31 in Q1 2021.
  • Altium Capital Management's portfolio value rose 34% quarter-over-quarter to $360M.

Based on Altium Capital Management's 13F filing for Q1 2021, filed 6 May 2021.